Sectoral Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.46M | Sell |
7,007
-998
| -12% | -$465K | 2.86% | 9 |
|
|
2025
Q4 | $3.63M | Buy |
8,005
+290
| +4% | +$125K | 2.91% | 9 |
|
|
2025
Q3 | $3.02M | Buy |
7,715
+770
| +11% | +$322K | 1.87% | 20 |
|
|
2025
Q2 | $3.09M | Buy |
6,945
+2,220
| +47% | +$1.02M | 2.04% | 7 |
|
|
2025
Q1 | $2.29M | Buy |
4,725
+1,055
| +29% | +$492K | 1.78% | 14 |
|
|
2024
Q4 | $1.48M | Sell |
3,670
-1,170
| -24% | -$542K | 0.99% | 28 |
|
|
2024
Q3 | $2.25M | Sell |
4,840
-3,810
| -44% | -$1.83M | 1.33% | 22 |
|
|
2024
Q2 | $4.05M | Buy |
8,650
+1,440
| +20% | +$625K | 1.65% | 19 |
|
|
2024
Q1 | $3.01M | Sell |
7,210
-2,009
| -22% | -$849K | 1.18% | 23 |
|
|
2023
Q4 | $3.75M | Buy |
9,219
+450
| +5% | +$166K | 1.62% | 18 |
|
|
2023
Q3 | $3.05M | Buy |
8,769
+605
| +7% | +$212K | 0.59% | 73 |
|
|
2023
Q2 | $2.87M | Buy |
8,164
+1,545
| +23% | +$521K | 0.48% | 74 |
|
|
2023
Q1 | $2.09M | Sell |
6,619
-400
| -6% | -$120K | 0.4% | 80 |
|
|
2022
Q4 | $2.03M | Sell |
7,019
-899
| -11% | -$274K | 0.39% | 79 |
|
|
2022
Q3 | $2.29M | Sell |
7,918
-200
| -2% | -$57.5K | 0.45% | 73 |
|
|
2022
Q2 | $2.29M | Buy |
8,118
+837
| +11% | +$224K | 0.46% | 77 |
|
|
2022
Q1 | $1.9M | Sell |
7,281
-490
| -6% | -$116K | 0.34% | 82 |
|
|
2021
Q4 | $1.71M | Sell |
7,771
-1,950
| -20% | -$379K | 0.26% | 86 |
|
|
2021
Q3 | $1.76M | Hold |
9,721
| – | – | 0.15% | 111 |
|
|
2021
Q2 | $1.96M | Sell |
9,721
-1,600
| -14% | -$335K | 0.16% | 106 |
|
|
2021
Q1 | $2.43M | Sell |
11,321
-5,600
| -33% | -$1.23M | 0.18% | 90 |
|
|
2020
Q4 | $4M | Buy |
16,921
+7,050
| +71% | +$1.62M | 0.28% | 71 |
|
|
2020
Q3 | $2.69M | Sell |
9,871
-4,800
| -33% | -$1.32M | 0.23% | 76 |
|
|
2020
Q2 | $4.26M | Sell |
14,671
-1,500
| -9% | -$407K | 0.39% | 68 |
|
|
2020
Q1 | $3.85M | Buy |
16,171
+100
| +0.6% | +$22.9K | 0.74% | 50 |
|
|
2019
Q4 | $3.52M | Buy |
16,071
+1,900
| +13% | +$385K | 0.53% | 51 |
|
|
2019
Q3 | $2.4M | Sell |
14,171
-23,600
| -62% | -$4.17M | 0.41% | 51 |
|
|
2019
Q2 | $6.93M | Buy |
37,771
+17,500
| +86% | +$3.06M | 0.83% | 45 |
|
|
2019
Q1 | $3.73M | Sell |
20,271
-15,946
| -44% | -$2.95M | 0.45% | 62 |
|
|
2018
Q4 | $6M | Sell |
36,217
-40,629
| -53% | -$7.04M | 0.82% | 44 |
|
|
2018
Q3 | $14.8M | Buy |
+76,846
| New | +$13.7M | 1.57% | 24 |
|
|
2018
Q2 | – | Sell |
-41,915
| Closed | -$6.83M | – | 73 |
|
|
2018
Q1 | $6.83M | Buy |
41,915
+5,200
| +14% | +$849K | 0.75% | 47 |
|
|
2017
Q4 | $5.5M | Buy |
36,715
+2,715
| +8% | +$402K | 0.69% | 45 |
|
|
2017
Q3 | $5.17M | Buy |
+34,000
| New | +$5.12M | 0.67% | 42 |
|
|
2016
Q4 | – | Sell |
-217,874
| Closed | -$19M | – | 62 |
|
|
2016
Q3 | $19M | Sell |
217,874
-13,701
| -6% | -$1.29M | 1.87% | 23 |
|
|
2016
Q2 | $19.9M | Sell |
231,575
-664,904
| -74% | -$57.5M | 2.06% | 21 |
|
|
2016
Q1 | $71.3M | Buy |
896,479
+208,279
| +30% | +$18.8M | 3.45% | 9 |
|
|
2015
Q4 | $86.6M | Sell |
688,200
-46,000
| -6% | -$5.55M | 3.69% | 8 |
|
|
2015
Q3 | $76.5M | Buy |
734,200
+135,400
| +23% | +$17.4M | 3.5% | 10 |
|
|
2015
Q2 | $73.9M | Buy |
598,800
+89,200
| +18% | +$11.2M | 3.08% | 11 |
|
|
2015
Q1 | $60.1M | Buy |
509,600
+297,350
| +140% | +$35.6M | 2.28% | 12 |
|
|
2014
Q4 | $25.2M | Sell |
212,250
-117,647
| -36% | -$13.3M | 1.13% | 32 |
|
|
2014
Q3 | $37.1M | Sell |
329,897
-749,567
| -69% | -$71.4M | 1.56% | 22 |
|
|
2014
Q2 | $102M | Sell |
1,079,464
-197,277
| -15% | -$13.8M | 4.33% | 5 |
|
|
2014
Q1 | $90.3M | Buy |
1,276,741
+44,583
| +4% | +$3.53M | 3.71% | 6 |
|
|
2013
Q4 | $91.5M | Sell |
1,232,158
-3,597
| -0.3% | -$250K | 3.95% | 5 |
|
|
2013
Q3 | $93.7M | Sell |
1,235,755
-1,290,259
| -51% | -$103M | 4.51% | 5 |
|
|
2013
Q2 | $202M | Buy |
+2,526,014
| New | +$186M | 5.98% | 1 |
|
Other funds holding VRTX
VCM
VPM
Sectoral Asset Management's VRTX Position: Q1 2026 in Review
Sectoral Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 12% in Q1 2026, selling an estimated $465K and leaving 7,007 shares worth $3.46M. The position accounts for 2.86% of the portfolio, ranked #9.
Sectoral Asset Management first reported a position in VRTX in Q2 2013 and has held it in 48 quarters since. The position peaked at $202M in Q2 2013. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Sectoral Asset Management held 7,007 shares of Vertex Pharmaceuticals worth $3.46M as of Q1 2026.
- Sectoral Asset Management sold 998 Vertex Pharmaceuticals shares in Q1 2026, an estimated $465K.
- Vertex Pharmaceuticals made up 2.86% of Sectoral Asset Management's portfolio in Q1 2026, its #9 holding.
- Sectoral Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 48 quarters since.
- Sectoral Asset Management's Vertex Pharmaceuticals position peaked at $202M in Q2 2013.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.